Gastric permeability and Helicobacter pylori

Gastroenterologia Polska

Volumn 10, Issue 4, 2003, Pages 305-315

  Matysiak Budnik, Tamara ^a   Heyman, Martine ^a   Mégraud, Francis ^b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Gastric barrier; Gastric permeability; Helicobacter pylori

Indexed keywords

CYTOKINE;

ALLERGY; ARTICLE; CARCINOGENESIS; CELIAC DISEASE; CELL LINE; CROHN DISEASE; CYTOKINE PRODUCTION; GASTRIC PERMEABILITY; HELICOBACTER PYLORI; HUMAN; INFLAMMATORY CELL; INTESTINE MUCOSA PERMEABILITY; PATHOGENESIS; STOMACH EPITHELIUM; STOMACH ULCER; TRANSCYTOSIS;

EID: 0142153049     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (135)

1. Crowe S.E., Luthra G.K., Perdue M.H.: Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut, 1997, 41, 785-792.
2. Mitomi H., Tanabe S., Igarashi M., Katsumata T., Arai N., Kikuchi S., Kiyohashi A., Okayasu I.: Autoimmune enteropathy with severe atrophic gastritis and colitis in an adult proposal of a generalized autoimmune disorder of the alimentary tract. Scand. J. Gastroenterol., 1998, 33, 716-720.
3. Schmitz H., Barmeyer C., Fromm M., Runkel N., Foss H.D., Bentzel C.J., Riecken E.O., Schulzke J.D.: Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology, 1999, 116, 301-309.
4. Puspok A., Oberhuber G., Wyatt J., Maier-Dobersberger T., Hammer J., Pfeffel F., Wrba F., Potzi R., Vogelsang H.: Gastroduodenal permeability in Crohn's disease. Eur. J. Clin. Invest., 1998, 28, 67-71.
5. Soderholm J.D., Olaison G., Peterson K.H., Franzen L.E., Lindmark T., Wiren M., Tagesson C., Sjodahl R.: Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut, 2002, 50, 307-313.
6. Soler A.P., Miller R.D., Laughlin K.V., Carp N.Z., Klurfeld D.M., Mullin J.M.: Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis, 1999, 20, 1425-1431.
7. Gotteland M., Isolauri E., Heyman M., Tome D., Desjeux J.F.: Antigen absorption in bacterial diarrhea: in vivo intestinal transport of beta-lactoglobulin in rabbits infected with the entero-adherent Escherichia coli strain RDEC-1. Pediatr. Res., 1989, 26, 237-240.
8. Heyman M., Corthier G., Petit A., Meslin J.C., Moreau C., Desjeux J. F.: Intestinal absorption of macromolecules during viral enteritis: an experimental study on rotavirus-infected conventional and germ- free mice. Pediatr. Res., 1987, 22, 72-78.
9. Crowe S.E., Perdue M.H.: Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology, 1992, 103, 1075-1095.
10. Heyman M., Grasset E., Ducroc R., Desjeux J.F.: Antigen absorption by the jejunal epithelium of children with cow's milk allergy. Pediatr. Res., 1988, 24, 197-202.
11. Tobey N.A., Hosseini S.S., Caymaz-Bor C., Wyatt H.R., Orlando G.S., Orlando R.C.: The role of pepsin in acid injury to esophageal epithelium. Am. J. Gastroenterol., 2001, 96, 3062-3070.
12. Davies N. M.: Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability. Aliment. Pharmacol. Ther., 1998, 12, 303-320.
13. Kiviluoto T., Mustonen H., Kivilaakso E.: Effect of barrier-breaking agents on intracellular pH and epithelial membrane resistances: studies in isolated Necturus antral mucosa exposed to luminal acid. Gastroenterology, 1989, 96, 1410-1408.
14. Davenport H.W.: Gastric mucosal injury by fatty and acetylsalicylic acid. Gastroenterology, 1964, 46, 245-253.
15. Davenport H.W., Warner H.A., Code C.F.: Functional significance of gastric mucosal barrier to sodium. Gastroenterology, 1968, 54, Suppl. 11.
16. Hollander F.: The two-component mucus barrier: Its activity in protecting the gastroduodenal mucosa against peptic ulceration. Arch. Intern. Med., 1954, 93, 107-120.
17. Ivey K.J.: Gastric mucosal barrier. Gastroenterology, 1971, 61, 247-257.
18. Teorell T.: On the permeability of the stomach for acids and some other substances. J. Gen. Physiol., 1939, 23, 263-274.
19. Catto-Smith A.G., Patrick M.K., Scott R.B., Davison J.S., Gall D.G.: Gastric response to mucosal IgE-mediated reactions. Am. J. Physiol., 1989, 257, G704-G708.
20. Curtis G.H., Gall D.G.: Macromolecular transport by rat gastric mucosa. Am. J. Physiol., 1992, 262, G1033-G1040.
21. Anderson J.M.: Molecular structure of tight junctions and their role in epithelial transport. N. Physiol. Sci., 2001, 16, 126-130.
22. Balda M.S., Fallon M.B., Van Itallie C.M., Anderson J.M.: Structure, regulation, and pathophysiology of tight junctions in the gastrointestinal tract. Yale J. Biol. Med., 1992, 65, 725-735.
23. Heiskala M., Peterson P.A., Yang Y.: The roles of claudin superfamily proteins in paracellular transport. Traffic, 2001, 2, 93-98.
24. Mitic L.L., Anderson J.M.: Molecular architecture of tight junctions. Annu. Rev. Physiol., 1998, 60, 121-142.
25. Claude P.: Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J. Membr. Biol., 1978, 39, 219-232.
26. Anderson J.M., Van Itallie C.M.: Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol., 1995, 269, G467-G475.
27. Balda M.S., Matter K.: Tight junctions. J. Cell. Sci., 1998, 111, 541-547.
28. Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., Rubin L.L.: Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell. Sci., 1997, 110, 1603-1613.
29. McCarthy K.M., Skare I.B., Stankewich M.C., Furuse M., Tsukita S., Rogers R.A., Lynch R.D., Schneeberger E.E.: Occludin is a functional component of the tight junction. J. Cell. Sci., 1996, 109, 2287-2298.
30. Fanning A.S., Mitic L.L., Anderson J.M.: Transmembrane proteins in the tight junction barrier. J. Am. Soc. Nephrol., 1999, 10, 1337-1345.
31. Morita K., Furuse M., Fujimoto K., Tsukita S.: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA, 1999, 96, 511-516.
32. Anderson J.M., Van Itallie C.M.: Tight junctions: closing in on the seal. Curr. Biol., 1999, 9, R922-R924.
33. Kubota K., Furuse M., Sasaki H., Sonoda N., Fujita K., Nagafuchi A., Tsukita S.: Ca (2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr. Biol. 1999, 9, 1035-1038.
34. Sonoda N., Furuse M., Sasaki H., Yonemura S., Katahira J., Horiguchi Y., Tsukita S.: Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J. Cell. Biol., 1999, 147, 195-204.
35. Madara J.L.: Intestinal absorptive cell tight junctions are linked to cytoskeleton. Am. J. Physiol., 1987, 253, C171-C175.
36. Madara J.L., Barenberg D., Carlson S.: Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell. Biol., 1986, 102, 2125-2136.
37. Madara J.L., Dharmsathaphorn K.: Occluding junction structure-function relationships in a cultured epithelial monolayer. J. Cell. Biol., 1985, 101, 2124-2133.
38. Denker B.M., Saha C., Khawaja S., Nigam S.K.: Involvement of a heterotrimeric G protein alpha subunit in tight junction biogenesis. J. Biol. Chem., 1996, 271, 25750-25753.
39. Matter K., Balda M.S.: Signalling to and from tight junctions. Nat. Rev., 2003, 4, 225-236.
40. Cope O., Blatt H., Ball M.R.: Gastric secretion III. The absorption of heavy water from the pouches of the body and antrum of the stomach of the dog. J. Clin. Invest., 1943, 22, 111-114.
41. Dyck W.P., Werther J.L., Rudick J., Janowitz H.D.: Electrolyte movement across canine antral and fundic gastric mucosa. Gastroenterology, 1969, 56, 488-495.
42. Spenney J.G., Shoemaker R.L., Sachs G.: Microelectrode studies of fundic gastric mucosa: cellular coupling and shunt conductance. J. Membr. Biol., 1974, 19, 105-128.
43. Davenport H.W.: Salicylate damage to the gastric mucosal barrier. N. Engl. J. Med., 1967, 276, 1307-1312.
44. Davenport H.W.: Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology, 1968, 54, 175-181.
45. Davenport H.W., Cohen B.J., Bree M., Davenport V.D.: Damage to the gastric mucosa: effects of salicylates and stimulation. Gastroenterology, 1965, 49, 189-196.
46. Ivey K.J., Morrison S., Gray C.: Effect of salicylates on the gastric mucosal barrier in man. J. Appl. Physiol., 1972, 33, 81-85.
47. Karlqvist P.A., Franzen L., Sjodahl R., Tagesson C.: Lysophosphatidylcholine and taurodeoxycholate increase stomach permeability to different-sized molecules. Scand. J. Gastroenterol., 1986, 21, 1039-1045.
48. Kivilaakso E., Silen W.: Pathogenesis of experimental gastric-mucosal injury. N. Engl. J. Med., 1979, 301, 364-369.
49. Kiviluoto T., Voipio J., Kivilaakso E.: Subepithelial tissue pH of rat gastric mucosa exposed to luminal acid, barrier breaking agents, and hemorrhagic shock. Gastroenterology, 1988, 94, 695-702.
50. Walker W.A., Cornell R., Davenport L.M., Isselbacher K.J.: Macromolecular absorption. Mechanism of horseradish peroxidase uptake and transport in adult and neonatal rat intestine. J. Cell. Biol., 1972, 54, 195-205.
51. Ducroc R., Heyman M., Beaufrere B., Morgat J.L., Desjeux J.F.: Horseradish peroxidase transport across rabbit jejunum and Peyer's patches in vitro. Am. J. Physiol., 1983, 245, G54-G58.
52. Heyman M., Ducroc R., Desjeux J.F., Morgat J.L.: Horseradish peroxidase transport across adult rabbit jejunum in vitro. Am. J. Physiol., 1982, 242, G558-G564.
53. Heyman M., Boudraa G., Sarrut S., Giraud M., Evans L., Touhami M., Desjeux J.F.: Macromolecular transport in jejunal mucosa of children with severe malnutrition: a quantitative study. J. Pediatr. Gastroenterol. Nutr., 1984, 3, 357-363.
54. Heyman M., Crain-Denoyelle A.M., Nath S.K., Desjeux J.F.: Quantification of protein transcytosis in the human colon carcinoma cell line CaCo-2. J. Cell. Physiol., 1990, 143, 391-395.
55. Heyman M., Desjeux J.F.: Significance of intestinal food protein transport. J. Pediatr. Gastroenterol. Nutr., 1992, 15, 48-57.
56. Ding S.Z., Crowe S. E.: Helicobacter pylori and the epithelial barrier. [in:] Helicobacter pylori: Basic Mechanisms to Clinical Cure, (eds) R.H. Hunt, G.N.J. Tytgat. Dordrecht, Boston, London: Kluwer Academic Publishers, 2002, 155-168.
57. Megraud F.: Impact of Helicobacter pylori virulence on the outcome of gastroduodenal diseases: lessons from the microbiologist. Dig. Dis., 2001, 19, 99-103.
58. Ernst P.B., Crowe S.E., Reyes V.E.: How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology, 1997, 113, S35-S42.
59. Israel D.A., Peek R. M.: Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment. Pharmacol. Ther., 2001, 15, 1271-1290.
60. Corthésy-Theulaz I., Porta N., Pringault E., Racine L., Bogdanova A., Kraehenbuhl J.P., Blum A.L., Michetti P., Philipott D.J.: Adhesion of Helicobacter pylori to polarized T84 human intestinal cell monolayers is pH dependent. Infect. Immun., 1996, 64, 3827-3832.
61. Evans D.G., Evans D.J. Jr, Graham D.Y.: Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology, 1992, 102, 1557-1567.
62. Neman-Simha V., Mégraud F., Corthésy-Theulaz I.: In vitro model for Campylobacter pylori adherence properties. Infect. Immun., 1988, 56, 3329-3333.
63. Segal E.D., Shon J., Tompkins L.S.: Characterization of Helicobacter pylori urease mutants. Infect. Immun., 1992, 60, 1883-1889.
64. Terres A.M., Pajares J.M., Hopkins A.M., Murphy A., Moran A., Baird A.W., Kelleher D.: Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect. Immun., 1998, 66, 2943-2950.
65. Segal E.D., Falkow S., Tompkins L.S.: Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl. Acad. Sci. USA, 1996, 93, 1259-1264.
66. Hemalatha S.G., Drumm B., Sherman P.: Adherence of Helicobacter pylori to human gastric epithelial cells in vitro. J. Med. Microbiol., 1991, 35, 197-202.
67. Smoot D.T., Resau J.H., Naab T., Desbordes B.C., Gilliam T., Bull-Henry K., Curry S.B., Nidiry J., Sewchand J., Mills-Robertson K.: Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect. Immun., 1993, 61, 350-355.
68. Papini E., Satin B., Norais N., de Bernard M., Telford J.L., Rappuoli R., Montecucco C.: Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest., 1998, 102, 813-820.
69. Pelicic V., Reyrat J.M., Sartori L., Pagliaccia C., Rappuoli R., Telford J.L., Montecucco C., Papini E.: Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology, 1999, 145, 2043-2050.
70. Hofman V., Ricci V., Galmiche A., Brest P., Auberger P., Rossi B., Boquet P., Hofman P.: Effect of Helicobacter pylori on polymorphonuclear leukocyte migration across polarized T84 epithelial cell monolayers: role of vacuolating toxin VacA and cag pathogenicity island. Infect. Immun., 2000, 68, 5225-5233.
71. de Bernard M., Arico B., Papini E., Rizzuto R., Grandi G., Rappuoli R., Montecucco C.: Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol. Microbiol., 1997, 26, 665-674.
72. Ashorn M., Cantet F., Mayo K., Megraud F.: Cytoskeletal rearrangements induced by Helicobacter pylori strains in epithelial cell culture: possible role of the cytotoxin. Dig. Dis. Sci., 2000, 45, 1774-1780.
73. Szabo I., Brutsche S., Tombola F., Moschioni M., Satin B., Telford J.L., Rappuoli R., Montecucco C., Papini E., Zoratti M.: Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J., 1999, 18, 5517-5527.
74. Tombola F., Morbiato L., Del Giudice G., Rappuoli R., Zoratti M., Papini E.: The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J. Clin. Invest., 2001, 108, 929-937.
75. Desai M.A., Vadgama P.M.: Enhanced H+ diffusion by NH4+/HCO3-: implications for Helicobacter pylori-associated peptic ulceration. Digestion, 1993, 54, 32-39.
76. Desai M.A., Vadgama P.M.: An in vitro study of enhanced H+ diffusion by urease action on urea. Implications for Helicobacter pylori-associated peptic ulceration. Scand. J. Gastroenterol., 1993, 28, 915-919.
77. Churin Y., Kardalinou E., Meyer T.F., Naumann M.: Pathogenicity island-dependent activation of Rho GTPases Rac1 and Cdc42 in Helicobacter pylori infection. Mol. Microbiol., 2001, 40, 815-823.
78. Selbach M., Moese S., Hurwitz R., Hauck C.R., Meyer T.F., Backert S.: The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J, 2003, 22, 515-528.
79. Amieva M.R., Vogelmann R., Covacci A., Tompkins L.S., Nelson W.J., Falkow S.: Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science, 2003, 300, 1430-1434.
80. Matysiak-Budnik T., Terpend K., Alain S., Sanson le Pors M.J., Desjeux J.F., Mégraud F., Heyman M.: Helicobacter pylori alters exogenous antigen absorption and processing across a digestive epithelial cell line. Infect. Immun., 1998, 66, 5785-5791.
81. Matysiak-Budnik T., Hashimoto K., Heyman M., de Mascarel A., Desjeux J.F., Megraud F.: Antral gastric permeability to antigens in mice is altered by infection with Helicobacter felis. Eur. J. Gastroenterol. Hepatol., 1999, 11, 1371-1377.
82. Ghiara P., Marchetti M., Blaser M.J., Tummuru M.K., Cover T.L., Segal E.D., Tompkins L.S., Rappuoli R.: Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect. Immun., 1995, 63, 4154-4160.
83. Borch K., Sjostedt C., Hannestad U., Soderholm J.D., Franzen L., Mardh S.: Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability. Dig. Dis. Sci., 1998, 43, 749-753.
84. Fukuda Y., Bamba H., Okui M., Tamura K., Tanida N., Satomi M., Shimoyama T., Nishigami T.: Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion, 2001, 63, Suppl. S1, 93-96.
85. Rabassa A.A., Goodgame R., Sutton F.M., Ou C.N., Rognerud C., Graham D.Y.: Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut, 1996, 39, 159-163.
86. Vera J.F., Gotteland M., Chavez E., Vial M.T., Kakarieka E., Brunser O.: Sucrose permeability in children with gastric damage and Helicobacter pylori infection. J. Pediatr. Gastroenterol. Nutr., 1997, 24, 506-511.
87. Goodgame R.W., Malaty H.M., Le-Zimaity H., Graham D.Y.: Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection. Helicobacter, 1997, 2, 44-47.
88. Graham D.Y.: Pathogenesis of increased sucrose permeability in H. pylori gastritis. Dig. Dis. Sci., 2000, 45, 889.
89. Milks L.C., Brontoli M.J., Cramer E.B.: Epithelial permeability and the transepithelial migration of human neutrophils. J. Cell. Biol., 1983, 96, 1241-1247.
90. Nash S., Stafford J., Madara J.L.: Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest., 1987, 80, 1104-1113.
91. Parsons P.E., Sugahara K., Cott G.R., Mason R.J., Henson P.M.: The effect of neutrophil migration and prolonged neutrophil contact on epithelial permeability. Am. J. Pathol., 1987, 129, 302-312.
92. Satin B., Norais N., Telford J., Rappuoli R., Murgia M., Montecucco C., Papini E.: Effect of Helicobacter pylori vacuolating toxin on maturation and extracellular release of procathepsin D and on epidermal growth factor degradation. J. Biol. Chem., 1997, 272, 25022-25028.
93. Mai U.E., Perez-Perez G.I., Allen J.B., Wahl S.M., Blaser M.J., Smith P.D.: Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J. Exp. Med., 1992, 175, 517-525.
94. Craig P.M., Territo M.C., Karnes W.E., Walsh J.H.: Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut, 1992, 33, 1020-1023.
95. Ferry D.M., Butt T.J., Broom M.F., Hunter J., Chadwick V.S.: Bacterial chemotactic oligopeptides and the intestinal mucosal barrier. Gastroenterology, 1989, 97, 61-67.
96. Innocenti M., Thoreson A.C., Perrero R.L., Stromberg E., Bolin I., Eriksson L., Svennerholm A.M., Quiding-Jarbrink M.: Helicobacter pylori-induced activation of human endothelial cells. Infect. Immun., 2002, 70, 4581-4590.
97. Odenbreit S., Puls J., Sedlmaier B., Gerland E., Fischer W., Haas R.: Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science, 2000, 287, 1497-1500.
98. Viala G., Chaput C., Boneca I.G., Girardin S.E., Moran A.P., Huerre M.R., Sansonetti P.J., Labigne A., Philpott D.J., Ferrero R.L.: Nod1-dependent proinflammatory responses to Helicobacter pylori infection in gastric epithelial cells. Gastroenterology, 2003, 124, A43.
99. Smith M.F.J., Mitchell A., Li G., Ding S., Fitzmaurice A.M., Ryan K., Crowe S.E., Goldberg J.B.: TLR2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem., 2003, 13 (in press).
100. Gaboriau-Routhiau V., Moreau M.C.: Oral tolerance to ovalbumin in mice: induction and long-term persistence unaffected by Staphylococcus aureus enterotoxin B and Clostridium perfringens type A enterotoxin. Pediatr. Res., 1997, 42, 503-508.
101. Strobel S., Ferguson A.: Modulation of intestinal and systemic immune responses to a fed protein antigen in mice. Gut, 1986, 27, 829-837.
102. Matysiak-Budnik T., van Niel G., Mégraud F., Mayo K., Bevilacqua C., Ganoriau-Routhiau V., Moreau M.C., Heyman M.: Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice. Infect. Immun., 2003, 71, 5219-5224.
103. Corrado G., Luzzi I., Lucarelli S., Frediani T., Pacchiarotti C., Cavaliere M., Rea P., Cardi E.: Positive association between Helicobacter pylori infection and food allergy in children. Scand. J. Gastroenterol., 1998, 33, 1135-1139.
104. Figura N., Perrone A., Gennari C., Orlandini G., Bianciardi L., Giannace R., Vaira D., Vagliasinti M., Rottoli P.: Food allergy and Helicobacter pylori infection. Ital. J. Gastroenterol. Hepatol., 1999, 31, 186-191.
105. Murakami K., Fujioka T., Nishizono A., Nagai J., Tokieda M., Kodama R., Kubota T., Nasu M.: Atopic dermatitis successfully treated by eradication of Helicobacter pylori. J. Gastroenterol., 1996, 31, 77-82.
106. Bohmeyer J., Heller A., Hartig C., Wetenberger-Treumann M., Huchzermeyer H., Otte H.G., Stadler R.: Association of chronic urticaria with Helicobacter pylori-induced antrum gastritis. Hautarzt, 1996, 47, 106-108.
107. Di Campli C., Gasbarrini A., Nucera E., Franceschi F., Ojetti V., Sanz T.E., Schiavino D., Pola P., Patriarca G., Gasbarrini G.: Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig. Dis. Sci., 1998, 43, 1226-1229.
108. Kalas D., Pronai L., Ferenczi K., Palos G., Daroczy J.: Connection between Helicobacter pylori infection and chronic gastrointestinal urticaria. Orv. Hetil., 1996, 137, 1969-1972.
109. Valsecchi R., Pigatto P.: Chronic urticaria and Helicobacter pylori. Acta Derm. Venereol., 1998, 78, 440-442.
110. Wedi B., Wagner S., Werfel T., Manns M.P., Kapp A.: Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int. Arch. Allergy Immunol., 1998, 116, 288-294.
111. Farkas H., Fust G., Fekete B., Karadi I., Varga L.: Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet, 2001, 358, 1695-1696.
112. Erel F., Sener O., Erdil A., Karaayvaz M., Gur G., Caliskaner Z., Ozanguc N.: Impact of Helicobacter pylori and Giardia lamblia infections on chronic urticaria. J. Investig. Allergol. Clin. Immunol., 2000, 10, 94-97.
113. Howden C.W.: No evidence for an association between H. pylori and idiopathic chronic urticaria. Dig. Dis. Sci., 1999, 44, 485-486.
114. Kosunen T.U., Hook-Nikanne J., Salomaa A., Sarna S., Aromaa A., Haahtela T.: Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin. Exp. Allergy, 2002, 32, 373-378.
115. Matricardi P.M., Rosmini F., Riondino S., Fortini M., Ferrigno L., Rapicetta M., Bonini S.: Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ, 2000, 320, 412-417.
116. Wustlich S., Brehler R., Luger T.A., Pohle T., Domschke W., Foerster E.: Helicobacter pylori as a possible bacterial focus of chronic urticaria. Dermatology, 1999, 198, 130-132.
117. Genta R.M., Lew G.M., Graham D.Y.: Changes in the gastric mucosa following eradication of Helicobacter pylori. Modern. Pathol., 1993, 6, 281-289.
118. Solcia E., Villani L., Fiocca R., Luinetti O., Boldorini R., Trespi E., Perego M., Alvisi C., Lazzaroni M., Bianchi P.G.: Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand. J. Gastroenterol. Suppl., 1994, 201, 28-34.
119. Witteman E.M., Mravunac M., Becx M.J., Hopman W.P., Verschoor J.S., Tytgat G.N., de Koning R.W.: Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J. Clin. Pathol., 1995, 48, 250-256.
120. Zerbib F., Lenk C., Sawan B., Cayla R., Broutet N., Carles B., de Mascarel A., Megraud F., Lamouliatte H.: Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients. Eur. J. Gastroenterol. Hepatol., 2000, 12, 719-725.
121. Matysiak-Budnik T., de Mascarel A., Abely M., Mayo K., Heyman M., Megraud F.: Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis. Scand. J. Gastroenterol., 2000, 35, 470-475.
122. Ohara T., Arakawa T., Higuchi K., Kaneda K.: Overexpression of co-stimulatory molecules in peripheral mononuclear cells of Helicobacter pylori-positive peptic ulcer patients: possible difference in host responsiveness compared with non-ulcer patients. Eur. J. Gastroenterol. Hepatol., 2001, 13, 11-18.
123. Ye G., Barrera C., Fan X., Gourley W.K., Crowe S.E., Ernst P.B., Reyes V.E.: Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection. J. Clin. Invest., 1997, 99, 1628-1636.
124. Soderholm J.D., Peterson K.H., Olaison G., Franzen L.E., Westrom B., Magnusson K.E., Sjodahl R.: Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology, 1999, 117, 65-72.
125. Feeney M.A., Murphy F., Clegg A.J., Trebble T.M., Sharer N.M., Snook J.A.: A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol., 2002, 14, 529-534.
126. Guslandi M., Fanti L., Testoni P.A.: Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment. Hepatogastroenterology, 2002, 49, 1296-1297.
127. Pearce C.B., Duncan H.D., Timmis L., Green J.R.: Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol., 2000, 12, 439-443.
128. Vare P.O., Heikius B., Silvennoinen J.A., Karttunen R., Niemela S.E., Lehtola J.K., Karttunen T.J.: Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scan. J. Gastroenterol., 2001, 36, 1295-1300.
129. Konturek P.C., Karczewska E., Dieterich W., Hahn E.G., Schuppan D.: Increased prevalence of Helicobacter pylori infection in patients with celiac disease. Am. J. Gastroenterol., 2000, 95, 3682-3683.
130. Diamanti A., Maino C., Niveloni S., Pedreira S., Vazquez H., Smecuol E., Fiorini A., Cabanne A., Bartellini M.A., Kogan Z., Valero J., Maurino E., Bai J.C.: Characterization of gastric mucosal lesions in patients with celiac disease: a prospective controlled study. Am. J. Gastroenterol., 1999, 94, 1313-1319.
131. Wu T.T., Hamilton S.R.: Lymphocytic gastritis: association with etiology and topology. Am. J. Surg. Pathol., 1999, 23, 153-158.
132. Haot J., Hamichi L., Wallez L., Mainguet P.: Lymphocytic gastritis: a newly described entity: a retrospective endoscopic and histological study. Gut, 1988, 29, 1258-12564.
133. Hayat M., Arora D.S., Dixon M.F., Clark B., O'Mahony S.: Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut, 1999, 45, 495-498.
134. Wolber R., Owen D., DelBuono L., Appelman H., Freeman H.: Lymphocytic gastritis in patients with celiac sprue or spruelike intestinal disease. Gastroenterology, 1990, 98, 310-315.
135. Dawson D.C., Cooke A.R.: Parallel pathways for ion transport across rat gastric mucosa: effect of ethanol. Am. J. Physiol., 1978, 235, E7-E15.